Heart failure with preserved ejection fraction: Refocusing on diastole

International Journal of Cardiology

Volumn 179, Issue , 2015, Pages 430-440

  Abbate, Antonio ^a   Arena, Ross ^b   Abouzaki, Nayef ^a   Van Tassell, Benjamin W ^a   Canada, Justin ^a   Shah, Keyur ^a   Biondi Zoccai, Giuseppe ^c   Voelkel, Norbert F ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cardiopulmonary; Diastole; Exercise; Heart failure; Physiology

Indexed keywords

3 (1 BIPHENYL 4 YLMETHYL 3 ETHOXYCARBONYL 1 BUTYLCARBAMOYL)PROPIONIC ACID PLUS VALSARTAN; ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; CELL PROTEIN; DIGOXIN; DIURETIC AGENT; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1; INTERLEUKIN 18; IRBESARTAN; ISOSORBIDE; IVABRADINE; NORADRENALIN; OSTEOPONTIN; PLACEBO; RANOLAZINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ROSUVASTATIN; SILDENAFIL; TINTIN; UNCLASSIFIED DRUG;

AEROBIC EXERCISE; AFRICAN AMERICAN; AGING; AORTA VALVE DISEASE; ARTERIAL STIFFNESS; CARDIOPULMONARY EXERCISE TEST; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; DIABETES MELLITUS; DIASTOLE; DIASTOLIC DYSFUNCTION; DIFFERENTIAL DIAGNOSIS; DOPPLER ECHOCARDIOGRAPHY; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ECHOCARDIOGRAPHY; ETHNIC DIFFERENCE; HEART CATHETERIZATION; HEART CONTRACTION; HEART DILATATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART LEFT VENTRICLE RELAXATION; HEART LEFT VENTRICLE SYSTOLIC FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE CONTRACTILITY; HEMODYNAMICS; HOSPITALIZATION; HUMAN; HYPERTENSION; IMMUNOPATHOGENESIS; IMPAIRED CONTRACTILE RESERVE; INTERVENTRICULAR DYSSYNCHRONY; INTRAVENTRICULAR DYSSYNCHRONY; LABORATORY TEST; LEFT VENTRICLE STIFFNESS; LUNG FUNCTION TEST; MEDICAL RESEARCH; METABOLIC SYNDROME X; MITRAL VALVE DISEASE; MORTALITY; MYOCARDIAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOPHYSIOLOGY; PERICARDIAL DISEASE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL EXAMINATION; PREVALENCE; PROGNOSIS; PROTEIN PROCESSING; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SEX DIFFERENCE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; SYSTOLIC DYSFUNCTION; TACHYCARDIA; VENTRICULO ARTERIAL COUPLING; HEART FAILURE; HEART STROKE VOLUME; PHYSIOLOGY; RISK FACTOR;

DIAGNOSIS, DIFFERENTIAL; DIASTOLE; HEART FAILURE; HUMANS; RISK FACTORS; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84920670391     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.11.106     Document Type: Review

References (111)

1. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis Eur. Heart J. 33 14 Jul 2012 1750 1757
2. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, E.Z. Soliman, P.D. Sorlie, N. Sotoodehnia, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, and M.B. Turner Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
3. E. Braunwald Heart failure JACC Heart Fail. 1 2013 1 20
4. W.J. Paulus, C. Tschope, J.E. Sanderson, C. Rusconi, F.A. Flachskampf, F.E. Rademakers, P. Marino, O.A. Smiseth, G. De Keulenaer, A.F. Leite-Moreira, A. Borbely, I. Edes, M.L. Handoko, S. Heymans, N. Pezzali, B. Pieske, K. Dickstein, A.G. Fraser, and D.L. Brutsaert How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur. Heart J. 28 2007 2539 2550
5. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M.A. Gomez-Sanchez, T. Jaarsma, L. Køber, G.Y. Lip, A.P. Maggioni, A. Parkhomenko, B.M. Pieske, B.A. Popescu, P.K. Rønnevik, F.H. Rutten, J. Schwitter, P. Seferovic, J. Stepinska, P.T. Trindade, A.A. Voors, F. Zannad, A. Zeiher, and ESC Committee for Practice Guidelines ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur. Heart J. 33 2012 1787 1847
6. C.W. Yancy, M. Jessup, B. Bozkurt, B. Butler, J. Butler, D.E. Casey Jr., M.H. Drazner, G.C. Fonarow, S.A. Geraci, T. Horwich, J.L. Januzzi, M.R. Johnson, E.K. Kasper, W.C. Levy, P.E. McBride, J.E. Mitchell, P.N. Peterson, B Riegel, F. Sam, L.W. Stevenson, W.H. Tang, E.J. Tsai, B.L. Wilkoff, and American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 62 2013 e147 e239
7. M. Senni, W.J. Paulus, A. Gavazzi, A.G. Fraser, J. Díez, S.D. Solomon, O.A. Smiseth, M. Guazzi, C.S. Lam, A.P. Maggioni, C. Tschöpe, M. Metra, S.L. Hummel, F. Edelmann, G. Ambrosio, A.J. Stewart Coats, G.S. Filippatos, M. Gheorghiade, S.D. Anker, D. Levy, M.A. Pfeffer, W.G. Stough, and B.M. Pieske New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes Eur. Heart J. 35 2014 2797 2815
8. A. Basuray, B. French, B. Ky, E. Vorovich, C. Olt, N.K. Sweitzer, T.P. Cappola, and J.C. Fang Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes Circulation 129 2014 2380 2387
9. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, E.L. Michelson, B. Olofsson, J. Ostergren, and CHARM Investigators and Committees Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-preserved trial Lancet 362 9386 Sep 6 2003 777 781
10. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, M.R. Zile, S. Anderson, M. Donovan, E. Iverson, C. Staiger, A. Ptaszynska, and I-PRESERVE Investigators Irbesartan in patients with heart failure and preserved ejection fraction N. Engl. J. Med. 359 23 Dec 4 2008 2456 2467
11. F. Edelmann, R. Wachter, A.G. Schmidt, E. Kraigher-Krainer, C. Colantonio, W. Kamke, A. Duvinage, R. Stahrenberg, K. Durstewitz, M. Löffler, H.D. Düngen, C. Tschöpe, C. Herrmann-Lingen, M. Halle, G. Hasenfuss, G. Gelbrich, B. Pieske, and Aldo-DHF Investigators Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 8 Feb 27 2013 781 791
12. M.M. Redfield, H.H. Chen, B.A. Borlaug, M.J. Semigran, K.L. Lee, G. Lewis, M.M. LeWinter, J.L. Rouleau, D.A. Bull, D.L. Mann, A. Deswal, L.W. Stevenson, M.M. Givertz, E.O. Ofili, C.M. O'Connor, G.M. Felker, S.R. Goldsmith, B.A. Bart, S.E. McNulty, J.C. Ibarra, G. Lin, J.K. Oh, M.R. Patel, R.J. Kim, R.P. Tracy, E.J. Velazquez, K.J. Anstrom, A.F. Hernandez, A.M. Mascette, E. Braunwald, and RELAX Trial Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 12 Mar 27 2013 1268 1277
13. C. Jacobshagen, L. Belardinelli, G. Hasenfuss, and L.S. Maier Ranolazine for the treatment of heart failure with preserved ejection fraction: background, aims, and design of the RALI-DHF study Clin. Cardiol. 34 7 Jul 2011 426 432
14. H. Persson, E. Lonn, M. Edner, L. Baruch, C.C. Lang, J.J. Morton, J. Ostergren, R.S. McKelvie, and Investigators of the CHARM Echocardiographic Substudy-CHARMES Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM echocardiographic substudy-CHARMES J. Am. Coll. Cardiol. 49 6 Feb 13 2007 687 694
15. M.R. Zile, J.S. Gottdiener, S.J. Hetzel, J.J. McMurray, M. Komajda, R. McKelvie, C.F. Baicu, B.M. Massie, P.E. Carson, and I-PRESERVE Investigators Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction Circulation 124 23 Dec 6 2011 2491 2501
16. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N. Engl. J. Med. 355 2006 251 259
17. J.G. Cleland, K. Swedberg, F. Follath, M. Komajda, A. Cohen-Solal, J.C. Aguilar, R. Dietz, A. Gavazzi, R. Hobbs, J. Korewicki, H.C. Madeira, V.S. Moiseyev, I. Preda, W.H. van Gilst, J. Widimsky, N. Freemantle, J. Eastaugh, and J. Mason Study group on diagnosis of the working group on heart failure of the European Society of Cardiology. The EuroHeart failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis Eur. Heart J. 24 5 Mar 2003 442 463
18. M. Haass, D.W. Kitzman, I.S. Anand, A. Miller, M.R. Zile, B.M. Massie, and P.E. Carson Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial Circ. Heart Fail. 4 3 May 2011 324 331
19. V.Y. Anjan, T.M. Loftus, M.A. Burke, N. Akhter, G.C. Fonarow, M. Gheorghiade, and S.J. Shah Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction Am. J. Cardiol. 110 6 Sep 15 2012 870 876
20. W.J. Paulus, and C. Tschöpe A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation J. Am. Coll. Cardiol. 62 4 Jul 23 2013 263 271
21. S.F. Mohammed, B.A. Borlaug, V.L. Roger, S.A. Mirzoyev, R.J. Rodeheffer, J.A. Chirinos, and M.M. Redfield Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study Circ. Heart Fail. 5 6 Nov 2012 710 719
22. M. Senni, C.M. Tribouilloy, R.J. Rodeheffer, S.J. Jacobsen, J.M. Evans, K.R. Bailey, and M.M. Redfield Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991 Circulation 98 21 Nov 24 1998 2282 2289
23. M. Senni, A. Gavazzi, F. Oliva, A. Mortara, R. Urso, M. Pozzoli, M. Metra, D. Lucci, L. Gonzini, V. Cirrincione, L. Montagna, A. Di Lenarda, A.P. Maggioni, L. Tavazzi, and IN HF Outcome investigators. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF outcome registry Int. J. Cardiol. 173 2 May 1 2014 163 169
24. M.R. Zile, C.F. Baicu, and W.H. Gaasch Diastolic heart failure - abnormalities in active relaxation and passive stiffness of the left ventricle N. Engl. J. Med. 350 2004 1953 1959
25. A. Borbély, J. van der Velden, Z. Papp, J.G. Bronzwaer, I. Edes, G.J. Stienen, and W.J. Paulus Cardiomyocyte stiffness in diastolic heart failure Circulation 111 6 Feb 15 2005 774 781
26. L. van Heerebeek, A. Borbély, H.W. Niessen, J.G. Bronzwaer, J. van der Velden, G.J. Stienen, W.A. Linke, G.J. Laarman, and W.J. Paulus Myocardial structure and function differ in systolic and diastolic heart failure Circulation 113 16 Apr 25 2006 1966 1973
27. L. van Heerebeek, C.P. Franssen, N. Hamdani, F.W. Verheugt, G.A. Somsen, and W.J. Paulus Molecular and cellular basis for diastolic dysfunction Curr. Heart Fail. Rep. 9 4 Dec 2012 293 302
28. M. Krüger, and W.A. Linke Titin-based mechanical signaling in normal and failing myocardium J. Mol. Cell. Cardiol. 46 2009 490 498
29. A. Rudolph, H. Abdel-Aty, S. Bohl, P. Boyé, A. Zagrosek, R. Dietz, and J. Schulz-Menger Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling J. Am. Coll. Cardiol. 53 3 Jan 20 2009 284 291
30. P.M. Okin, S.E. Kjeldsen, B. Dahlöf, and R.B. Devereux Racial differences in incident heart failure during antihypertensive therapy Circ. Cardiovasc. Qual. Outcomes 4 2 Mar 2011 157 164
31. S.L. Rodrigues, L.C. Angelo, A.C. Pereira, J.E. Krieger, and J.G. Mill Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals Int. J. Cardiol. 135 3 Jul 10 2009 323 330
32. K. Eguchi, B. Boden-Albala, Z. Jin, T. Rundek, R.L. Sacco, S. Homma, and M.R. Di Tullio Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population Am. J. Cardiol. 101 12 Jun 15 2008 1787 1791
33. B. Andrén, L. Lind, G. Hedenstierna, and H. Lithell Impaired systolic and diastolic function and ventricular arrhythmia are common in normotensive healthy elderly men with left ventricular hypertrophy Coron. Artery Dis. 10 2 1999 111 117
34. D.H. Katz, L. Beussink, A.J. Sauer, B.H. Freed, M.A. Burke, and S.J. Shah Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction Am. J. Cardiol. 112 2013 1158 1164
35. A.M. Shah, S.J. Shah, I.S. Anand, N.K. Sweitzer, E. O'Meara, J.F. Heitner, G. Sopko, G. Li, S.F. Assmann, S.M. McKinlay, B. Pitt, M.A. Pfeffer, S.D. Solomon, and TOPCAT Investigators Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial Circ. Heart Fail. 7 1 Jan 2014 104 115
36. J. Díez Mechanisms of cardiac fibrosis in hypertension J. Clin. Hypertens. 9 7 Jul 2007 546 550
37. B.W. Van Tassell, S. Toldo, E. Mezzaroma, and A. Abbate Targeting interleukin-1 in heart disease Circulation 128 2013 1910 1923
38. L.C. O'Brien, E. Mezzaroma, B.W. Van Tassell, C. Marchetti, S. Carbone, A. Abbate, and S. Toldo Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure Mol. Med. 20 2014 221 229
39. R.L. Rudominer, M.J. Roman, R.B. Devereux, S.A. Paget, J.E. Schwartz, M.D. Lockshin, M.K. Crow, L. Sammaritano, D.M. Levine, and J.E. Salmon Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction Arthritis Rheum. 60 2009 22 29 (2626148)
40. K.P. Liang, E. Myasoedova, C.S. Crowson, J.M. Davis, V.L. Roger, B.L. Karon, D.D. Borgeson, T.M. Therneau, R.J. Rodeheffer, and S.E. Gabriel Increased prevalence of diastolic dysfunction in rheumatoid arthritis Ann. Rheum. Dis. 69 2010 1665 1670
41. R. Zhang, J. Zhao, A. Mandveno, and J.D. Potter Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation Circ. Res. 76 6 Jun 1995 1028 1035
42. L. Li, J. Desantiago, G. Chu, E.G. Kranias, and D.M. Bers Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation Am. J. Physiol. Heart Circ. Physiol. 278 3 Mar 2000 H769 H779
43. M.L. Asp, J.J. Martindale, F.I. Heinis, W. Wang, and J.M. Metzger Calcium mishandling in diastolic dysfunction: mechanisms and potential therapies Biochim. Biophys. Acta 2013 1833 895 900
44. I. Ikonomidis, J.P. Lekakis, M. Nikolaou, I. Paraskevaidis, I. Andreadou, T. Kaplanoglou, P. Katsimbri, G. Skarantavos, P.N. Soucacos, and D.T. Kremastinos Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis Circulation 117 2008 2662 2669
45. A. Platis, Q. Yu, D. Moore, E. Khojeini, P. Tsau, and D. Larson The effect of daily administration of IL-18 on cardiac structure and function Perfusion 23 2008 237 242
46. I. Ikonomidis, S. Tzortzis, J. Lekakis, I. Paraskevaidis, I. Andreadou, M. Nikolaou, T. Kaplanoglou, P. Katsimbri, G. Skarantavos, P. Soucacos, and D.T. Kremastinos Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis Heart 95 18 Sep 2009 1502 1507
47. I. Ikonomidis, M. Nikolaou, I. Dimopoulou, I. Paraskevaidis, J. Lekakis, I. Mavrou, M. Tzanela, P. Kopterides, I. Tsangaris, A. Armaganidis, and D.T. Kremastinos Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome Shock 33 2010 141 148
48. B.W. Van Tassell, R. Arena, G. Biondi-Zoccai, J. McNair Canada, C. Oddi, N.A. Abouzaki, A. Jahangiri, R.A. Falcao, M.C. Kontos, K.B. Shah, N.F. Voelkel, C.A. Dinarello, and A. Abbate Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study) Am. J. Cardiol. 113 2014 321 327
49. F.H. Verbrugge, M. Dupont, P. Steels, L. Grieten, M. Malbrain, W.H. Tang, and W. Mullens Abdominal contributions to cardiorenal dysfunction in congestive heart failure J. Am. Coll. Cardiol. 62 2013 485 495
50. B.A. Borlaug, R.A. Nishimura, P. Sorajja, C.S. Lam, and M.M. Redfield Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ. Heart Fail. 3 2010 588 595
51. M.M. Abudiab, M.M. Redfield, V. Melenovsky, T.P. Olson, D.A. Kass, B.D. Johnson, and B.A. Borlaug Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction Eur. J. Heart Fail. 15 2013 776 785
52. Y.T. Tan, F. Wenzelburger, E. Lee, G. Heatlie, F. Leyva, K. Patel, M. Frenneaux, and J.E. Sanderson The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion J. Am. Coll. Cardiol. 54 2009 36 46
53. T.T. Phan, K. Abozguia, G. Nallur Shivu, G. Mahadevan, I. Ahmed, L. Williams, G. Dwivedi, K. Patel, P. Steendijk, H. Ashrafian, A. Henning, and M. Frenneaux Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency J. Am. Coll. Cardiol. 54 2009 402 409
54. B.A. Borlaug, T.P. Olson, C.S. Lam, K.S. Flood, A. Lerman, B.D. Johnson, and M.M. Redfield Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction J. Am. Coll. Cardiol. 56 2010 845 854
55. S. Chattopadhyay, M.F. Alamgir, N.P. Nikitin, A.S. Rigby, A.L. Clark, and J.G. Cleland Lack of diastolic reserve in patients with heart failure and normal ejection fraction Circ. Heart Fail. 3 2010 35 43
56. B.A. Borlaug The pathophysiology of heart failure with preserved ejection fraction Nat. Rev. Cardiol. 11 2014 507 515
57. D.G. Tilley, and H.A. Rockman Role of beta-adrenergic receptor signaling and desensitization in heart failure: new concepts and prospects for treatment Expert. Rev. Cardiovasc. Ther. 4 2006 417 432
58. S.V. Naga Prasad, C. Perrino, and H.A. Rockman Role of phosphoinositide 3-kinase in cardiac function and heart failure Trends Cardiovasc. Med. 13 5 Jul 2003 206 212
59. M.R. Zile, B. Kjellstrom, T. Bennett, Y. Cho, C.F. Baicu, M.F. Aaron, W.T. Abraham, R.C. Bourge, and F.J. Kueffer Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction Circ. Heart Fail. 6 3 May 2013 508 516
60. M. Kawaguchi, I. Hay, B. Fetics, and D.A. Kass Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations Circulation 107 5 Feb 11 2003 714 720
61. B.A. Borlaug, C.S. Lam, V.L. Roger, R.J. Rodeheffer, and M.M. Redfield Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction J. Am. Coll. Cardiol. 54 5 Jul 28 2009 410 418
62. B.A. Borlaug, V. Melenovsky, S.D. Russell, K. Kessler, K. Pacak, L.C. Becker, and D.A. Kass Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction Circulation 114 20 Nov 14 2006 2138 2147
63. C.S. Lam, V.L. Roger, R.J. Rodeheffer, B.A. Borlaug, F.T. Enders, and M.M. Redfield Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study J. Am. Coll. Cardiol. 53 13 Mar 31 2009 1119 1126
64. S. Dorfs, W. Zeh, W. Hochholzer, N. Jander, R.P. Kienzle, B. Pieske, and F.J. Neumann Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction Eur. Heart J. 35 2014 3103 3112
65. B.A. Borlaug, R.A. Nishimura, P. Sorajja, C.S. Lam, and M.M. Redfield Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ. Heart Fail. 3 2010 588 595
66. M.J. Haykowsky, P.H. Brubaker, J.M. John, K.P. Stewart, T.M. Morgan, and D.W. Kitzman Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction J. Am. Coll. Cardiol. 58 3 Jul 12 2011 265 274
67. M. Guazzi, J. Myers, and R. Arena Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure J. Am. Coll. Cardiol. 46 10 Nov 15 2005 1883 1890
68. M. Guazzi, L.P. Cahalin, and R. Arena Cardiopulmonary exercise testing as a diagnostic tool for the detection of left-sided pulmonary hypertension in heart failure J. Card. Fail. 19 2013 461 467
69. R. Arena, P. Brubaker, B. Moore, and D. Kitzman The oxygen uptake efficiency slope is reduced in older patients with heart failure and a normal ejection fraction Int. J. Cardiol. 144 2010 101 102
70. L.P. Cahalin, P. Chase, R. Arena, J. Myers, D. Bensimhon, M.A. Peberdy, E. Ashley, E. West, D.E. Forman, S. Pinkstaff, C.J. Lavie, and M. Guazzi A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure Heart Fail. Rev. 18 1 Jan 2013 79 94
71. M. Guazzi, J. Myers, M.A. Peberdy, D. Bensimhon, P. Chase, and R. Arena Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction J. Cardiopulm. Rehabil. Prev. 30 2010 165 172
72. M. Guazzi, J. Myers, and R. Arena Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure J. Am. Coll. Cardiol. 46 2005 1883 1890
73. J.M. Cahill, E. Ryan, B. Travers, M. Ryder, M. Ledwidge, and K. McDonald Progression of preserved systolic function heart failure to systolic dysfunction - a natural history study Int. J. Cardiol. 106 2006 95 102
74. K. Loboz-Grudzień, A. Kowalska, B. Brzezińska, L. Sokalski, and J. Jaroch Early predictors of adverse left ventricular remodelling after myocardial infarction treated by primary angioplasty Cardiol. J. 14 2007 238 245
75. B. Villari, G. Vassalli, and E.S. Monrad Normalization of diastolic dysfunction in aortic stenosis late after valve replacement Circulation 91 1995 2353 2358
76. H.P. Krayenbuehl, O.M. Hess, and E.S. Monrad Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement Circulation 79 1989 744 755
77. C.F. Azevedo, M. Nigri, and M.L. Higuchi Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease J. Am. Coll. Cardiol. 56 2010 278 287
78. S. Ather, W. Chan, B. Bozkurt, D. Aguilar, K. Ramasubbu, A.A. Zachariah, X.H. Wehrens, and A. Deswal Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J. Am. Coll. Cardiol. 59 2012 998 1005
79. V.Y. Anjan, T.M. Loftus, M.A. Burke, N. Akhter, G.C. Fonarow, M. Gheorghiade, and S.J. Shah Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction Am. J. Cardiol. 110 6 Sep 15 2012 870 876
80. D.J. van Veldhuisen, G.C. Linssen, T. Jaarsma, W.H. van Gilst, A.W. Hoes, J.G. Tijssen, W.J. Paulus, A.A. Voors, and H.L. Hillege B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction J. Am. Coll. Cardiol. 61 14 Apr 9 2013 1498 1506
81. B. Pitt, M.A. Pfeffer, S.F. Assmann, R. Boineau, I.S. Anand, B. Claggett, N. Clausell, A.S. Desai, R. Diaz, J.L. Fleg, I. Gordeev, B. Harty, J.F. Heitner, C.T. Kenwood, E.F. Lewis, E. O'Meara, J.L. Probstfield, T. Shaburishvili, S.J. Shah, S.D. Solomon, N.K. Sweitzer, S. Yang, S.M. McKinlay, and TOPCAT Investigators Spironolactone for heart failure with preserved ejection fraction N. Engl. J. Med. 370 15 Apr 10 2014 1383 1392
82. S.F. Nagueh Echocardiographic assessment of left ventricular relaxation and cardiac filling pressures Curr. Heart Fail. Rep. 6 3 Sep 2009 154 159
83. W.C. Little, and J.K. Oh Echocardiographic evaluation of diastolic function can be used to guide clinical care Circulation 120 2009 802 809
84. S.R. Ommen, R.A. Nishimura, C.P. Appleton, F.A. Miller, J.K. Oh, M.M. Redfield, and A.J. Tajik Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study Circulation 102 2000 1788 1794
85. A.M. Shah, B. Claggett, N.K. Sweitzer, S.J. Shah, I.S. Anand, E. O'Meara, A.S. Desai, J.F. Heitner, G. Li, J. Fang, J. Rouleau, M.R. Zile, V. Markov, V. Ryabov, G. Reis, S.F. Assmann, S.M. McKinlay, B. Pitt, M.A. Pfeffer, and S.D. Solomon Cardiac Structure and function and prognosis in heart failure with preserved ejection fraction: findings from the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial Circ. Heart Fail. 7 2014 740 751
86. B.A. Borlaug, R.A. Nishimura, P. Sorajja, C.S. Lam, and M.M. Redfield Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ. Heart Fail. 3 2010 588 595
87. M.I. Burgess, C. Jenkins, J.E. Sharman, and T.H. Marwick Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise J. Am. Coll. Cardiol. 47 9 May 2 2006 1891 1900
88. A. Kumar, R. Anel, E. Bunnell, K. Habet, S. Zanotti, S. Marshall, A. Neumann, A. Ali, M. Cheang, C. Kavinsky, and J.E. Parrillo Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects Crit. Care Med. 32 3 Mar 2004 691 699
89. N. Fujimoto, B.A. Borlaug, G.D. Lewis, J.L. Hastings, K.M. Shafer, P.S. Bhella, G. Carrick-Ranson, and B.D. Levine Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure Circulation 127 2013 55 62
90. G.J. Balady, R. Arena, K. Sietsema, J. Myers, L. Coke, G.F. Fletcher, D. Forman, B. Franklin, M. Guazzi, M. Gulati, S.J. Keteyian, C.J. Lavie, R. Macko, D. Mancini, R.V. Milani, American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research Clinician's guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association Circulation 122 2 2010 191 225
91. M. Guazzi, V. Adams, V. Conraads, M. Halle, A. Mezzani, L. Vanhees, R. Arena, G.F. Fletcher, D.E. Forman, D.W. Kitzman, C.J. Lavie, J. Myers, European Association for Cardiovascular Prevention & Rehabilitation, and American Heart Association EACPR/AHA scientific statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations Circulation 126 18 Oct 30 2012 2261 2274
92. T.S. Rector, P.E. Carson, I.S. Anand, J.J. McMurray, M.R. Zile, R.S. McKelvie, M. Komajda, M. Kuskowski, B.M. Massie, and I-PRESERVE Trial Investigators Assessment of long-term effects of irbesartan on heart failure with preserved ejection fraction as measured by the Minnesota living with heart failure questionnaire in the irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial Circ. Heart Fail. 5 2 Mar 1 2012 217 225
93. S.D. Solomon, M. Zile, B. Pieske, A. Voors, A. Shah, E. Kraigher-Krainer, V. Shi, T. Bransford, M. Takeuchi, J. Gong, M. Lefkowitz, M. Packer, and J.J. McMurray Prospective comparison of ARNI with ARB on management of heart failure with preserved ejection fraction (PARAMOUNT) investigators. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial Lancet 380 9851 Oct 20 2012 1387 1395
94. J.J. McMurray, M. Packer, A.S. Desai, J. Gong, M.P. Lefkowitz, A.R. Rizkala, J.L. Rouleau, V.C. Shi, S.D. Solomon, K. Swedberg, M.R. Zile, and PARADIGM-HF Investigators and Committees Angiotensin-neprilysin inhibition versus enalapril in heart failure N. Engl. J. Med. 371 11 Sep 11 2014 993 1004
95. Accessed on http://www.clinicaltrials.gov/ct2/show/NCT01920711 (on September 26, 2014)
96. M. Guazzi, M. Vicenzi, R. Arena, and M.D. Guazzi Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study Circulation 124 2 Jul 12 2011 164 174
97. W. Kosmala, D.J. Holland, A. Rojek, L. Wright, M. Przewlocka-Kosmala, and T.H. Marwick Effect of if-channel inhibition on hemodynamics and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial J. Am. Coll. Cardiol. 62 2013 1330 1338
98. Accessed on http://www.clinicaltrials.gov/ct2/show/NCT02173548 (on September 26, 2014)
99. D.W. Kitzman, P.H. Brubaker, D.M. Herrington, T.M. Morgan, K.P. Stewart, W.G. Hundley, A. Abdelhamed, and M.J. Haykowsky Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial J. Am. Coll. Cardiol. 62 7 Aug 13 2013 584 592
100. K. Nolte, C. Herrmann-Lingen, R. Wachter, G. Gelbrich, H.D. Düngen, A. Duvinage, N. Hoischen, K. von Oehsen, S. Schwarz, G. Hasenfuss, M. Halle, B. Pieske, and F. Edelmann Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial Eur. J. Prev. Cardiol. Mar 19 2014
101. F. Edelmann, G. Gelbrich, H.D. Düngen, S. Fröhling, R. Wachter, R. Stahrenberg, L. Binder, A. Töpper, D.J. Lashki, S. Schwarz, C. Herrmann-Lingen, M. Löffler, G. Hasenfuss, M. Halle, and B. Pieske Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: results of the Ex-DHF (exercise training in diastolic heart failure) pilot study J. Am. Coll. Cardiol. 58 17 Oct 18 2011 1780 1791
102. F.M. Gomez-Soto, S.P. Romero, J.A. Bernal, M.A. Escobar, J.L. Puerto, J.L. Andrey, P. Ruiz, and F. Gomez Mortality and morbidity of newly diagnosed heart failure treated with statins: a propensity-adjusted cohort study Int. J. Cardiol. 140 2 Apr 15 2010 210 218
103. F. Tehrani, R. Morrissey, A. Phan, C. Chien, and E.R. Schwarz Statin therapy in patients with diastolic heart failure Clin. Cardiol. 33 4 Apr 2010 E1 E5
104. Gissi-HF Investigators, L. Tavazzi, A.P. Maggioni, R. Marchioli, S. Barlera, M.G. Franzosi, R. Latini, D. Lucci, G.L. Nicolosi, M. Porcu, and G. Tognoni Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 372 9645 Oct 4 2008 1231 1239
105. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
106. A. Ahmed, M.W. Rich, J.L. Fleg, M.R. Zile, J.B. Young, D.W. Kitzman, T.E. Love, W.S. Aronow, K.F. Adams Jr, and M. Gheorghiade Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial Circulation. 114 2006 397 403
107. F.A. Zouein, L.E. de Castro Bras, D.V. da Costa, M.L. Lindsey, M. Kurdi, and G.W. Booz Heart failure with preserved ejection fraction: emerging drug strategies J. Cardiovasc. Pharmacol. 62 2013 13 21
108. D.M. Konstantinou, Y.S. Chatzizisis, and G.D. Giannoglou Pathophysiology-based novel pharmacotherapy for heart failure with preserved ejection fraction Pharmacol. Ther. 140 2013 156 166
109. M.R. Zile, W.H. Gaasch, I.S. Anand, M. Haass, W.C. Little, A.B. Miller, J. Lopez-Sendon, J.R. Teerlink, M. White, J.J. McMurray, M. Komajda, R. McKelvie, A. Ptaszynska, S.J. Hetzel, B.M. Massie, P.E. Carson, and I-Preserve Investigators Mode of death in patients with heart failure and a preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction study (I-Preserve) trial Circulation 121 12 Mar 30 2010 1393 1405
110. P. Almeida, J. Rodrigues, P. Lourenço, M.J. Maciel, and P. Bettencourt Prognostic significance of applying the European Society of Cardiology consensus algorithm for heart failure with preserved systolic function diagnosis Clin. Cardiol. 35 12 Dec 2012 770 776
111. J. Butler, G.C. Fonarow, M.R. Zile, C.S. Lam, L. Roessig, E.B. Schelbert, S.J. Shah, A. Ahmed, R.O. Bonow, J.G. Cleland, R.J. Cody, O. Chioncel, S.P. Collins, P. Dunnmon, G. Filippatos, M.P. Lefkowitz, C.N. Marti, J.J. McMurray, F. Misselwitz, S. Nodari, C. O'Connor, M.A. Pfeffer, B. Pieske, B. Pitt, G. Rosano, H.N. Sabbah, M. Senni, S.D. Solomon, N. Stockbridge, J.R. Teerlink, V.V. Georgiopoulou, and M. Gheorghiade Developing therapies for heart failure with preserved ejection fraction: current state and future directions JACC Heart Fail. 2 2 Apr 2014 97 112